(MedPage Today) — Markers of systemic inflammation and mitochondrial stress were reduced after psilocybin therapy in Parkinson’s disease patients with mood dysfunction, a small nonrandomized trial showed.
Relative to baseline, an inflammatory…
Source link
Psilocybin Tied to Lower Inflammation in Parkinson's Trial
